Compare NNNN & CSWC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NNNN | CSWC |
|---|---|---|
| Founded | 2021 | 1961 |
| Country | Germany | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Textiles |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.4B |
| IPO Year | 2025 | N/A |
| Metric | NNNN | CSWC |
|---|---|---|
| Price | $25.65 | $23.19 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $23.50 |
| AVG Volume (30 Days) | 73.0K | ★ 689.9K |
| Earning Date | 04-28-2026 | 02-02-2026 |
| Dividend Yield | N/A | ★ 11.13% |
| EPS Growth | N/A | ★ 26.97 |
| EPS | 0.06 | ★ 1.82 |
| Revenue | $6,920,153.00 | ★ $226,745,000.00 |
| Revenue This Year | N/A | $13.97 |
| Revenue Next Year | N/A | $7.62 |
| P/E Ratio | $410.25 | ★ $12.64 |
| Revenue Growth | N/A | ★ 14.25 |
| 52 Week Low | $5.18 | $17.46 |
| 52 Week High | $55.65 | $23.86 |
| Indicator | NNNN | CSWC |
|---|---|---|
| Relative Strength Index (RSI) | 44.80 | 49.01 |
| Support Level | $22.10 | $22.60 |
| Resistance Level | $34.00 | $23.84 |
| Average True Range (ATR) | 6.84 | 0.45 |
| MACD | -0.40 | -0.09 |
| Stochastic Oscillator | 22.21 | 21.77 |
Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.
Capital Southwest Corp is a U.S.-based investment company that specializes in providing customized financing to middle market companies across various industries. The company's investment objective is to produce attractive risk-adjusted returns by generating current income from debt investments and capital appreciation from equity and equity related investments. It focuses on providing flexible financing solutions through partnerships with business owners, management teams, and financial sponsors. The company's portfolio may include senior debt, second lien, and subordinated debt, preferred stocks, common stocks, and warrants. The primary source company's revenue comprises interest income and dividend income from investments made as well as management fees.